Recorded Chinese product: 复方丁香罗勒口服混悬液复方丁香罗勒口服混悬液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

碳酸钙是一种在国家药监局注册认定的药品。该药品含有三硅酸镁、氢氧化铝、碳酸钙-071e21a8等成分。

该药品关联的活性成分包括:三硅酸镁Sangui Suanmei、氢氧化铝Qingyang Hualv、碳酸钙Tansuan Gai。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:西安迪赛生物药业有限责任公司Chinese legal name: 西安迪赛生物药业有限责任公司。

您可以探索含有相同成分的其他药品:三硅酸镁-06079ab6成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 复方丁香罗勒口服混悬液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 三硅酸镁Sangui Suanmei, 氢氧化铝Qingyang Hualv, 碳酸钙Tansuan Gai.

Manufacturers recorded for this product: 西安迪赛生物药业有限责任公司Chinese legal name: 西安迪赛生物药业有限责任公司.

Explore other medicines containing the same ingredient: 三硅酸镁 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 复方丁香罗勒口服混悬液Recorded Chinese product: 复方丁香罗勒口服混悬液
  • 规格Specification: 100ml×1瓶100 mL × 1 bottles

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 西安迪赛生物药业有限责任公司Chinese legal name: 西安迪赛生物药业有限责任公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20110144

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20110144

Manufacturer

Chinese legal name: 西安迪赛生物药业有限责任公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

100 mL × 1 bottles

中文说明书原文Original Chinese source label

批准文号

国药准字H20110144

生产企业

西安迪赛生物药业有限责任公司(国产)

适应症

用于治疗成人及儿童急、慢性腹泻。

用法用量

用前摇匀,口服给药。|1.成人:一次40ml,一日3次。|2.儿童:6个月以下一次3ml,一日3次;6个月至1岁一次5ml,一日3次;1至2岁一次10ml,一日3次;2岁以上一次20ml~40ml,一日3次。3天为一疗程,症状改善不理想者可继续服用一疗程。

不良反应

临床试验未发现本品可引起明显不良反应。

禁忌

对本品过敏者禁用。

注意事项

1.本品忌与四环素族抗生素同服,以免影响四环素的疗效。|2.与抗胆碱药同用时应先服抗胆碱药,以免影响抗胆碱药的吸收。

贮藏

密封,置阴凉处。

规格

100ml×1瓶

证据Evidence

  • 批准文号: 国药准字H20110144
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.